New call for volunteers in North West London for COVID-19 vaccine booster study
A COVID-19 vaccine booster study running in North West London is now recruiting it’s second group of volunteers, after successfully recruiting to the first part of the trial.
There are two recruiting sites locally — Northwick Park Hospital in Harrow (part of London North West University Healthcare NHS Trust) and The Good Practice in Chelsea.
Participants will receive a ‘booster’ vaccine to tackle COVID-19 infections, as part of an ongoing clinical study, run by the pharmaceutical company Sanofi with the adjuvanted recombinant COVID-19 vaccine they are developing in partnership with GSK.
The purpose of this study is to examine to what extent a single booster injection safely creates a broad immune response against the different COVID-19 variants, in participants who have previously been fully vaccinated with an authorised COVID-19 vaccine.
Participants will be asked to attend a minimum of six study visits, and their health will be monitored for 12 months. Those interested in volunteering for the trial can find out more by visiting the study website.
COVID-19 Booster Vaccine Clinical Study | Sanofi Studies
The purpose of this study is to test a new COVID-19 vaccine to determine if it is safe and works to stimulate an immune response that may prevent COVID-19 disease. COVID-19 is a new, contagious disease that has quickly infected many people all over the world.
The study is open to adults aged 18-years-old and above, with participants enrolled across two groups (or cohorts), who have previously been vaccinated against COVID-19. A broad range of people may be included, from those who are healthy to those with health problems that put them at risk for complications due to COVID-19.
Those involved may contribute to the development of an additional vaccine that works for the good of global public health. Initial data from the study are expected to be available in quarter 4 of 2021.
A proportion of potential participants will be identified through the NHS COVID-19 Vaccine Research Registry, which currently has over 511,000 people signed up. To register interest in vaccine studies and sign up to be contacted by researchers, people can visit the NHS COVID-19 Vaccine Research Registry (www.nhs.uk/researchcontact).
Coronavirus (COVID-19) vaccine research studies
If you take part in a vaccine study you'll need to visit the hospital, or other research site, a few times over 6 to 12 months. At these visits, you'll usually: be told about the research study have the chance to ask any questions have blood tests have an injection, which may or may not be the COVID-19 vaccine Between visits, you'll be asked to tell the research team about any symptoms you have.
Dr Ashley Whittington, Principal Investigator of the trial at Northwick Park Hospital, said: “Volunteers in our region have already played a major role in helping us find vaccines that work for COVID-19. “Testing booster vaccines is the next step we need to take to protect as many people as possible as we adapt to living with COVID-19. I’m proud we are delivering this important study and giving local people the opportunity to take part.”
Jan du Plessis, PM and Research Coordinator at The Good Practice in Chelsea, said: “We've already achieved so much in developing our understanding of COVID-19. But there is still much more we need to explore so it's vital this research continues. “It's great we can offer local people the opportunity to take part in this study at The Good Practice. We will be promoting the study within Brompton Health PCN. The booster studies are an important next step and I'm pleased our community will be a part of it.”
Professor Adam Finn, Chief Investigator for the study said: “Throughout the pandemic we have seen excellent engagement and participation from the public within multiple pivotal vaccine studies. By examining the safety and effectiveness of the booster vaccine from Sanofi, it’s hoped researchers and participants can help add another option to our current portfolio of vaccines. “Booster vaccines from different suppliers will give us a broader range of vaccines and help us to reinforce supply as we look to boost immunity in the population going forward, as needed.”
Professor Andrew Ustianowski, National Clinical Lead for the UK NIHR COVID Vaccine Research Programme, said: “In addition to the several other COVID-19 vaccine studies running across the UK, this latest booster study from Sanofi will help inform future vaccine plans across the UK and beyond. “As more of the population become fully vaccinated, research and studies such as this continue to strengthen our understanding of how we can help protect everyone against coronavirus moving forward.”
- Adam Finn can be reached for interviews, please speak to Holly Ayres -
- For media requests with NIHR, contact firstname.lastname@example.org or 020 3328 6730
- There are expected around 600 volunteers across at least 5 NIHR sites, including:
- Queen Alexandra Hospital Portsmouth (Wessex)
- Northwick Park Hospital (North West London)
- The Good Practice (GP practice, North West London)
- Rotherham Doncaster and South Humber NHS Foundation Trust
- Halton Hospital (North West Coast)
About the National Institute for Health Research (NIHR)
The mission of the National Institute for Health Research (NIHR) is to improve the health and wealth of the nation through research. We do this by:
- Funding high quality, timely research that benefits the NHS, public health and social care;
- Investing in world-class expertise, facilities and a skilled delivery workforce to translate discoveries into improved treatments and services;
- Partnering with patients, service users, carers and communities, improving the relevance, quality and impact of our research;
- Attracting, training and supporting the best researchers to tackle complex health and social care challenges;
- Collaborating with other public funders, charities and industry to help shape a cohesive and globally competitive research system;
- Funding applied global health research and training to meet the needs of the poorest people in low-and-middle-income countries.
NIHR is funded by the Department of Health and Social Care. Its work in low and middle-income countries is principally funded through UK Aid from the UK government.
Volunteering for COVID-19 vaccine clinical trials:
People wishing to volunteer to support clinical trials can sign up for information on Covid-19 vaccine trials with the NHS Covid-19 Vaccine Research Registry, developed in partnership with NHS Digital. It is helping large numbers of people to be recruited into trials rapidly over the coming months - potentially meaning effective vaccines for coronavirus can be found as soon as possible.
The service was commissioned as part of the UK Government’s Vaccine Taskforce in conjunction with the National Institute for Health Research (NIHR) and the Northern Ireland, Scottish and Welsh Governments.
Anyone living in the UK can sign up online to take part in the trials through the NHS, giving permission for researchers to contact you if they think you’re a good fit. Once you sign up, you can withdraw at any time and request that your details be removed from the COVID-19 Vaccine Research Registry. The process takes about 5 minutes to complete.
More information can be found: NHS.UK/coronavirus